668 related articles for article (PubMed ID: 25733813)
21. Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action.
Brauer R; Wang LC; Woon ST; Bridewell DJ; Henare K; Malinger D; Palmer BD; Vogel SN; Kieda C; Tijono SM; Ching LM
Neoplasia; 2010 Sep; 12(9):755-65. PubMed ID: 20824052
[TBL] [Abstract][Full Text] [Related]
22. A novel small molecule, Rosline, inhibits growth and induces caspase-dependent apoptosis in human lung cancer cells A549 through a reactive oxygen species-dependent mechanism.
Zhao T; Feng Y; Jin W; Pan H; Li H; Zhao Y
Cell Biol Int; 2016 Jun; 40(6):686-95. PubMed ID: 27006094
[TBL] [Abstract][Full Text] [Related]
23. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
Meng LQ; Liu C; Luo YH; Piao XJ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Zang YQ; Li J; Fang NZ; Cui YD; Jin CH
Mol Med Rep; 2018 Feb; 17(2):2626-2634. PubMed ID: 29207064
[TBL] [Abstract][Full Text] [Related]
24. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
25. Calotropis gigantea extract induces apoptosis through extrinsic/intrinsic pathways and reactive oxygen species generation in A549 and NCI-H1299 non-small cell lung cancer cells.
Lee J; Jang HJ; Chun H; Pham TH; Bak Y; Shin JW; Jin H; Kim YI; Ryu HW; Oh SR; Yoon DY
BMC Complement Altern Med; 2019 Jun; 19(1):134. PubMed ID: 31215445
[TBL] [Abstract][Full Text] [Related]
26. Upregulation and activation of p53 by erastin‑induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells.
Huang C; Yang M; Deng J; Li P; Su W; Jiang R
Oncol Rep; 2018 Oct; 40(4):2363-2370. PubMed ID: 30066882
[TBL] [Abstract][Full Text] [Related]
27. Isolinderalactone inhibits proliferation of A549 human non‑small cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway.
Chang WA; Lin ES; Tsai MJ; Huang MS; Kuo PL
Mol Med Rep; 2014 May; 9(5):1653-9. PubMed ID: 24604009
[TBL] [Abstract][Full Text] [Related]
28. IRE1α-TRAF2-ASK1 pathway is involved in CSTMP-induced apoptosis and ER stress in human non-small cell lung cancer A549 cells.
Zhang J; Liang Y; Lin Y; Liu Y; YouYou ; Yin W
Biomed Pharmacother; 2016 Aug; 82():281-9. PubMed ID: 27470364
[TBL] [Abstract][Full Text] [Related]
29. Mst1 regulates non-small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F‑actin pathways.
Zhang W; Liu K; Pei Y; Ma J; Tan J; Zhao J
Int J Oncol; 2018 Dec; 53(6):2409-2422. PubMed ID: 30320378
[TBL] [Abstract][Full Text] [Related]
30. Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species.
Park SH; Kim JH; Chi GY; Kim GY; Chang YC; Moon SK; Nam SW; Kim WJ; Yoo YH; Choi YH
Toxicol Lett; 2012 Aug; 212(3):252-61. PubMed ID: 22721804
[TBL] [Abstract][Full Text] [Related]
31. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
Luo M; Mo J; Yu Q; Zhou S; Ning R; Zhang Y; Su C; Wang H; Cui J
Biomed Pharmacother; 2018 Oct; 106():593-598. PubMed ID: 29990847
[TBL] [Abstract][Full Text] [Related]
32. Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells.
Vinod Prabhu V; Elangovan P; Niranjali Devaraj S; Sakthivel KM
Gene; 2018 Dec; 679():352-359. PubMed ID: 30218747
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Proteomic Analysis of Cellular Resistance to the Nanoparticle Abraxane.
Zhao M; Li H; Bu X; Lei C; Fang Q; Hu Z
ACS Nano; 2015 Oct; 9(10):10099-112. PubMed ID: 26324059
[TBL] [Abstract][Full Text] [Related]
34. Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer.
Wei G; Xu Y; Peng T; Yan J; Wang Z; Sun Z
J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28296008
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.
Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z
Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650
[TBL] [Abstract][Full Text] [Related]
36. Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
Zhang L; Qiang P; Yu J; Miao Y; Chen Z; Qu J; Zhao Q; Chen Z; Liu Y; Yao X; Liu B; Cui L; Jing H; Sun G
Autophagy; 2019 Mar; 15(3):391-406. PubMed ID: 30145925
[TBL] [Abstract][Full Text] [Related]
37. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.
Tang ZH; Zhang LL; Li T; Lu JH; Ma DL; Leung CH; Chen XP; Jiang HL; Wang YT; Lu JJ
Oncotarget; 2015 Dec; 6(41):43911-26. PubMed ID: 26549806
[TBL] [Abstract][Full Text] [Related]
38. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Suppresses macrophage capping protein beyond STING activation.
Xiao Z; Cui X; Liu F; Wang Y; Liu X; Zhou W; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167149. PubMed ID: 38565383
[TBL] [Abstract][Full Text] [Related]
39. Coptisine-induced cell cycle arrest at G2/M phase and reactive oxygen species-dependent mitochondria-mediated apoptosis in non-small-cell lung cancer A549 cells.
Rao PC; Begum S; Sahai M; Sriram DS
Tumour Biol; 2017 Mar; 39(3):1010428317694565. PubMed ID: 28351307
[TBL] [Abstract][Full Text] [Related]
40. DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular.
Buchanan CM; Shih JH; Astin JW; Rewcastle GW; Flanagan JU; Crosier PS; Shepherd PR
Clin Sci (Lond); 2012 May; 122(10):449-57. PubMed ID: 22142330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
